- 01A safety record belongs to the product that was tested
Scenesse (the approved form of MT1) and Vyleesi (bremelanotide, developed from MT2) have FDA-reviewed safety data because each was tested as a specific, quality-controlled product 1516. Melanotan 2 itself has data from 23 men in three small studies between 1996 and 2000 123, and vials sold online held 4.32 to 8.84 mg against a 10 mg label 4. A vial sold as MT1 or MT2 shares a name with that research and none of its safety record.
Melanotan 2 has been tested in 23 men across three small studies from 1996 to 2000, and only 3 of them were checked for a tan 123. People buy it for a tan without the sun and often get nausea, yawning, a lost appetite and, in men, unplanned erections, because one molecule switches on several receptors at once. Vials sold online hold less than their label says 4, and case reports link it to melanoma and to muscle breakdown with kidney injury 67.
Melanotan 2 at a glance
| Question | Answer |
|---|---|
| Also called | Melanotan II, MT-II, MT2, the 'Barbie drug' |
| What it is | A lab-made ring-shaped peptide of 7 amino acids that copies alpha-MSH 1 |
| Sold for | Tanning, libido, and sometimes appetite loss |
| Status | Not approved as a medicine by FDA, the EMA or the UK's MHRA, for any use |
| Human evidence | A 3-man pilot (1996) and two erection trials in 20 men (1998, 2000) 123; no trial of how well it tans, how long a tan lasts or long-term safety |
| Known risks | Nausea, yawning, darker and new moles, priapism; in case reports, melanoma, muscle breakdown, kidney injury and a brain-swelling emergency |
| Approved relatives | Scenesse (afamelanotide, the approved form of MT1) and Vyleesi (bremelanotide, developed from MT2) |
What is melanotan 2?
Melanotan 2 is a synthetic version of alpha-melanocyte-stimulating hormone (alpha-MSH), the hormone the body releases after sun exposure to tell pigment cells to make more melanin. Researchers at the University of Arizona built melanotan 1 and melanotan 2 in the 1980s and 1990s as sunless-tanning agents, partly with the hope of protecting fair-skinned people from skin cancer 9. Melanotan 2 is a ring-shaped (cyclic) peptide of 7 amino acids, held closed by a chemical bridge, and the ring makes it far more potent and longer lasting than natural alpha-MSH 19.
Melanotan 2 never went through drug approval. It reaches people mostly as freeze-dried powder in small vials, bought online, mixed with water and injected under the skin 47; nasal sprays are sold too. The vials usually carry a 'research use only' label. That label means nobody has made or checked the product for use in people; it is a legal disclaimer, and it tells you nothing about safety.
How melanotan 2 works
Melanotan 2 is non-selective: it switches on at least four melanocortin receptors (the docking sites that alpha-MSH and related hormones act on), and each receptor drives a different effect 9. The table shows why a person who wants a tan also gets nausea, yawning and erections.
| Receptor | Where it sits | What switching it on does |
|---|---|---|
| MC1R | Pigment cells (melanocytes) in skin and moles | More dark melanin: the tan, darker freckles and moles |
| MC4R | Brain | Erections and sexual desire, yawning and stretching, lower appetite, nausea |
| MC3R | Brain and other tissues | Energy balance and appetite |
| MC5R | Oil and sweat glands | Gland secretion; the role in people is unclear |
In the 1996 pilot, melanotan 2 darkened skin in 2 of 3 men, and the change was measured in the face, upper body and buttock a week after the last injection 1. Buttock skin rarely sees daylight, so this suggests melanotan 2 can darken skin without direct sun, though the study did not control sun exposure. Many users add sun or sunbeds to speed the tan, and that extra UV is a large part of the skin-cancer worry.
Melanotan 1 vs melanotan 2: is MT1 safer?
Only the approved MT1 implant, Scenesse, has a measured safety record, from placebo-controlled trials in people with a diagnosed light-sensitivity disorder 14. MT1 acts mostly on the pigment receptor, so it would be expected to cause fewer erections and less appetite loss than MT2, but no study has compared MT1 bought online with MT2. A gray-market MT1 vial carries the same unknown-contents problem as an MT2 vial, and both darken moles.
| Feature | Melanotan 1 (MT1) | Melanotan 2 (MT2) |
|---|---|---|
| Structure | Straight chain of 13 amino acids | Ring of 7 amino acids |
| Main receptors | Mostly MC1R (pigment) | MC1R, MC3R, MC4R and MC5R 9 |
| Approved version | Afamelanotide (Scenesse) implant, FDA 2019, for erythropoietic protoporphyria (an inherited disorder that makes sunlight painful) | None; bremelanotide (Vyleesi) was developed from it |
| Human evidence | Two placebo-controlled trials in 168 people with erythropoietic protoporphyria 14 | A 3-man pilot and two small erection trials, 1996 to 2000 123 |
| Common side effects | Implant-site reactions, nausea, fatigue, dizziness, darker skin and new moles 15 | Nausea, yawning, lower appetite, erections 12; darker and new moles in case reports 56 |
What the human trials found
Three small studies, 23 men in total, are all the published controlled human data on melanotan 2, and two of them tested erections, not tanning 123.
| Year | Who | What was tested | What happened |
|---|---|---|---|
| 1996 | 3 healthy men | Injections alternating with salt-water placebo, single-blind (the men did not know which shot was which), at rising amounts | Darker skin in 2 of 3; spontaneous erections on and off for 1 to 5 hours after each injection; mild nausea; sleepiness and fatigue in 1 of 2 men at the top level 1 |
| 1998 | 10 men with psychogenic erectile dysfunction (erection problems with no physical cause, often linked to stress or anxiety) | Double-blind, placebo-controlled crossover (each man had both drug and placebo), erections monitored for 6 hours | Erections in 8 of 10; strong rigidity for 38 minutes on average vs 3 minutes on placebo; more nausea, yawning and lower appetite 2 |
| 2000 | 10 men with erectile dysfunction and physical risk factors | Double-blind, placebo-controlled crossover, erections monitored for 6 hours | Erections after 12 of 19 injections vs 1 of 21 placebo doses; strong rigidity for 45 vs 2 minutes; higher sexual desire; severe nausea after 4 of 19 injections 3 |
Both erection trials used one dose level of peptide made for the study, injected in a clinic and monitored for 6 hours 23. No published trial has tested melanotan 2 for tanning in more than 3 people, measured how long a melanotan tan lasts, followed repeated courses, or tracked users for years. Development then moved to bremelanotide (PT-141), a melanotan 2 derivative aimed at the sexual effect 9. If erections are the reason for interest, read the erectile dysfunction or low libido guides first; both conditions have studied, approved treatments that a doctor can go through with you.
Melanotan 2 side effects
Nobody knows how often melanotan 2 causes any of these problems, because no large or long study exists. The table sorts them by what the evidence is.
| Type | Examples | What the evidence is |
|---|---|---|
| Common, short-term | Nausea, yawning and stretching, lower appetite, sleepiness and tiredness, spontaneous erections | Seen in the trials of 3, 10 and 10 men 123 |
| Pigment changes | Darker freckles and moles, crops of new moles | Case reports 56 |
| Rare and serious | Melanoma; priapism (an erection that will not go down); muscle breakdown (rhabdomyolysis) with kidney injury; kidney infarction (part of a kidney dying from a blocked blood supply); posterior reversible encephalopathy syndrome (PRES), a brain-swelling emergency | Case reports 671011; FDA lists melanoma, PRES, a stimulant-like toxic reaction and priapism among the published serious events 12 |
| From the product | Infection or abscess, injection-site reactions, allergic reactions, nasal irritation from sprays | Depends on what is in the vial and how it is mixed and injected |
People with a personal or family history of melanoma or many atypical moles, people with heart disease, high blood pressure or kidney disease, and anyone pregnant or breastfeeding have the most to lose from melanotan 2, and no study has included them.
Interactions
No study has tested melanotan 2 alongside other drugs. Erectile dysfunction drugs such as sildenafil or tadalafil add a second trigger for erections, which raises the concern about priapism. The Vyleesi label warns that bremelanotide may slow stomach emptying and says to avoid it with naltrexone taken by mouth 16; melanotan 2 has never been checked for the same effect.
Does melanotan 2 cause skin cancer?
Case reports link melanotan 2 to melanoma, and case reports cannot prove that melanotan 2 caused it. In one report from Denmark, a 20-year-old woman with fair skin (Fitzpatrick type II) used a 3 to 4 week course of melanotan 2 injections to boost sunbed tanning, and a black mole on her buttock proved to be melanoma three months later 6. In another, a man with a past melanoma and many atypical moles developed crops of new moles, and his existing moles darkened and grew, after he injected a synthetic alpha-MSH tanning peptide; the moles faded after he stopped 5.
As the drug is unlicensed and incompletely tested, the extent and types of adverse effects are unknown.Hjuler KF, Lorentzen HF, Dermatology, 2014 6
Three things make melanotan 2 a skin-cancer concern. It stimulates the same pigment cells that become melanoma; users often add sunbeds or sunbathing; and darker, changing moles make a new melanoma harder to spot. No study has shown that a melanotan 2 tan protects against sunburn.
What is in a melanotan 2 vial
A Danish and UK team bought melanotan 2 vials from three web shops, each labeled 10 mg, and measured the contents with liquid chromatography and mass spectrometry, lab tests that separate, identify and weigh each substance. The vials held between 4.32 and 8.84 mg of melanotan 2, and vials from two of the shops held 4.1 to 5.9% unknown impurities 4. One vial could hold about twice as much as another, plus substances nobody has identified.
No study has measured how much melanotan 2 is absorbed from a nasal spray, so the amount that reaches the body is even less predictable, and sprays carry the same quality problems as vials.
Is melanotan 2 legal? US status in November 2026
Melanotan 2 is not an FDA-approved drug for any use. FDA had placed it in Category 2, its list of compounding ingredients that may carry significant safety risks, citing published reports of melanoma, PRES, a stimulant-like toxic reaction and priapism. The people who nominated it then withdrew, and by April 2026 FDA's page listed melanotan 2 as nominated but withdrawn 12. Leaving that list does not make it eligible for compounding. FDA has put melanotan 2, alongside the copper peptide GHK-Cu, on the agenda of its Pharmacy Compounding Advisory Committee, which FDA says will meet before the end of February 2027 8.
If FDA later added melanotan 2 to the 503A bulks list (the ingredients that compounding pharmacies, which mix a drug for one patient's prescription, may use), pharmacies could make it for individual patients under set conditions, and FDA still would not have reviewed whether it works or is safe. For tested athletes, the World Anti-Doping Agency bans at all times any drug with no current approval for human use (its S0 class), and melanotan 2 has no such approval anywhere 13.
Other research peptides sold the same way
The approved drugs from the same family
Two melanocortin drugs did reach approval in 2019. Afamelanotide (Scenesse), the approved form of MT1, is an implant placed by trained clinicians for erythropoietic protoporphyria; in two placebo-controlled trials of 168 patients it increased the time they could spend in direct sun without pain 14. Bremelanotide (Vyleesi), developed from melanotan 2, is an on-demand injection for low sexual desire in premenopausal women; 40% of patients in its trials had nausea, and it briefly raises blood pressure after each dose 16. The PT-141 guide covers bremelanotide in full.
Each approval covers one molecule, made to a standard and given by a set route to a defined group of patients, so neither safety record carries over to a vial sold as melanotan 2.
If you have used melanotan 2: what to watch and which tests help
The emergency signs in the side-effects section apply here too. Beyond those, four steps help.
- 1Stop and keep the vialStopping melanotan 2 ends the exposure; in one report, new moles faded after the peptide was stopped 5. Keep the vial or packaging so a clinician can see what you took.
- 2Photograph your molesTake clear photos of your skin now, including your back and the soles of your feet, so you and a dermatologist can compare later.
- 3Check with the ABCDE ruleLook for Asymmetry, an irregular Border, more than one Color, a Diameter over 6 mm, and Evolving size, shape or color.
- 4Tell your clinicianSay that you used melanotan 2, how long ago, and whether it was injected or sprayed; pigment changes and lab results read differently with that history.
Feel well, with no muscle pain, weakness or dark urine? A skin check is the main follow-up, and blood tests are for when symptoms appear or a clinician asks for them.
When a clinician suspects muscle or kidney injury after melanotan 2, the usual blood and urine tests are creatine kinase (CK, an enzyme that leaks from damaged muscle), creatinine and eGFR (kidney filtration), potassium (released from damaged muscle), and a urinalysis. A high CK, a rising creatinine or a high potassium after melanotan 2 needs a clinician the same day; do not wait for a repeat test first. In the published case of a man who injected melanotan 2 bought online, by his own account six times the starting amount he had been told to use, his heart raced, his muscles shook, and his urine dipstick showed 3+ blood with almost no red cells under the microscope 7. That pattern fits myoglobin, a muscle protein, though his urine also held red cell casts, a sign of kidney injury; the urinalysis guide explains how a dipstick and microscopy can disagree.
Tests that catch muscle and kidney injury
CalculatoreGFR calculatorGot a creatinine result from a stable, routine test? Turn it into an eGFR. While creatinine is changing, as in muscle or kidney injury, eGFR is unreliable and a clinician should read it.Work it out A single CK or creatinine value is a snapshot. If yours is high, ask your clinician when to repeat it, often within a few days, and whether you need fluids. Hard exercise in the 48 hours before the test can push CK into the thousands on its own, so say if you trained (exercise before a blood test). The kidney function guide explains what a change in creatinine means, and the urine test reader walks through each line of a urinalysis.
Free, no accountRead your blood testHad CK, creatinine or potassium checked after melanotan 2? Read each line of the report your clinician ordered.Read my results
Safer ways to get a tan
Self-tanners and spray tans with DHA (dihydroxyacetone, a sugar that browns the top layer of skin) color the skin without UV, fade over about a week, and give almost no sun protection, so sunscreen is still needed. No UV tan from the sun or a sunbed is safe, because the darkening is itself a sign of DNA damage in skin cells. People with a light-sensitivity disorder, such as erythropoietic protoporphyria, have an approved option through a specialist 15.
Citations
- Dorr RT, Lines R, Levine N, et al. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sciences, 1996;58(20):1777-84.
- Wessells H, Fuciarelli K, Hansen J, et al. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. Journal of Urology, 1998;160(2):389-93.
- Wessells H, Gralnek D, Dorr R, et al. Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urology, 2000;56(4):641-6.
- Breindahl T, Evans-Brown M, Hindersson P, et al. Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet. Drug Testing and Analysis, 2015;7(2):164-72.
- Cardones AR, Grichnik JM. alpha-Melanocyte-stimulating hormone-induced eruptive nevi. Archives of Dermatology, 2009;145(4):441-4.
- Hjuler KF, Lorentzen HF. Melanoma associated with the use of melanotan-II. Dermatology, 2014;228(1):34-6.
- Nelson ME, Bryant SM, Aks SE. Melanotan II injection resulting in systemic toxicity and rhabdomyolysis. Clinical Toxicology, 2012;50(10):1169-73.
- US Food and Drug Administration. February 2027 meeting of the Pharmacy Compounding Advisory Committee (agenda: LL-37, GHK-Cu, dihexa acetate, melanotan II, PEG-MGF). Page current as of 15 April 2026.
- Hadley ME, Dorr RT. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides, 2006;27(4):921-30.
- Peters B, Hadimeri H, Wahlberg R, Afghahi H. Melanotan II: a possible cause of renal infarction: review of the literature and case report. CEN Case Reports, 2020;9(2):159-61.
- Kaski D, Stafford N, Mehta A, et al. Melanotan and the posterior reversible encephalopathy syndrome. Annals of Internal Medicine, 2013;158(9):707-8.
- US Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks (melanotan II, nominated but withdrawn; content current as of 22 April 2026).
- World Anti-Doping Agency. Prohibited List (S0, non-approved substances).
- Langendonk JG, Balwani M, Anderson KE, et al. Afamelanotide for erythropoietic protoporphyria. New England Journal of Medicine, 2015;373(1):48-59.
- Scenesse (afamelanotide implant) prescribing information. US Food and Drug Administration, 2019.
- Vyleesi (bremelanotide injection) prescribing information. US Food and Drug Administration, 2019.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.






